Tag: proved-more
-
Morphosys moves closer to getting first antibody drug on market
German biotech Morphosys moved a step closer to getting its first antibody drug onto the market as its licensee, Johnson & Johnson unit Jenssen, reported positive results from a phase 3 study of psoriasis drug guselkumab. Johnson & Johnson said earlier the experimental biotech drug proved more effective at clearing moderate to severe cases of…
-
Thailand’s king recovering after respiratory infection: palace
Thailand's 88-year-old King Bhumibol Adulyadej, the world's longest reigning monarch, is recovering after a respiratory infection, the palace said in a statement on Saturday. The king has no fever and is breathing normally after doctors administered antibiotics to treat an inflammation of his left lung on Sep. 29, it said. A team of physicians would…
-
J&J psoriasis drug tops placebo, Humira in late stage study
(Reuters) – An experimental biotech drug developed by Johnson & Johnson proved more effective at clearing moderate to severe cases of the skin condition plaque psoriasis than a placebo or Abbvie Inc's big-selling Humira, according to data from a late stage study presented on Saturday. More than 73 percent of patients who received guselkumab experienced…
-
Thailand still golden for Chinese tourists despite Zika fears
By Amy Sawitta Lefevre and Panarat Thepgumpanat BANGKOK (Reuters) – Confirmation that the Zika virus had caused microcephaly in Thailand is not likely to scare off large numbers of Chinese tourists due to jet in for holidays in the next week, tourists and industry operators said. Thailand reported on Friday the first confirmed cases in…